Vijaya Diagnostic Centre Limited

BSE: VIJAYA543350ISIN INE043W01024

Healthcare
Healthcare Service Provider
BSE 1000

Share price

₹1,424.85-23.10 (-1.60%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹1,592.00
52W low: ₹847.90
Off 52W high: -10.50%
1M return: +0.13%
3M return: +2.56%
6M return: +19.81%
1Y return: +39.02%
20D avg volume: 8,780
50 DMA: ₹1,461.71
200 DMA: ₹1,239.05

Key ratios Consolidated

Market cap: ₹14,676 Cr
Current price: ₹1,424.85
52W high / low: ₹1,592.00 / ₹847.90
Face value: ₹1.00
P/E: 72.05
P/B: 13.88
EPS (TTM): ₹19.78
Book value / share: ₹102.66
ROE: —
ROCE: 19.20%
Operating margin: —
Net margin: —
Debt / equity: 0.00
Net debt: ₹-39.68 Cr
Interest cover: 8.00
Dividend yield: 0.14%
Dividend / share (TTM): ₹2.00
Payout: 10.11%
Cash conversion cycle: -5.2 days

Financials

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24
Income statement
	255.39	230.98	219.38	205.21	201.56	188.05	173.24	168.98	182.95	156.22	155.21	132.69
	4.95	8.53	2.40	5.10	6.25	7.05	5.55	4.70	4.51	3.56	3.25	5.11
	260.34	239.51	221.78	210.31	207.81	195.10	178.79	173.68	187.46	159.78	158.46	137.80
	180.92	168.57	157.51	152.09	149.83	142.90	130.39	126.97	130.27	117.88	114.59	100.99
	28.26	25.60	24.93	24.03	24.32	21.41	22.17	20.85	22.99	18.76	18.81	15.99
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—
	38.35	37.48	33.84	33.04	32.26	31.61	28.40	28.55	27.84	27.36	24.52	23.03
	11.38	11.00	9.32	8.60	7.83	7.49	7.19	6.82	6.47	6.26	6.19	6.06
	26.90	25.12	24.33	24.34	22.27	20.89	18.82	18.30	16.84	16.63	16.30	14.54
	76.03	69.37	65.09	62.09	63.16	61.50	53.81	52.44	56.14	48.86	48.76	41.37
	79.42	70.94	64.27	58.22	57.98	52.21	48.40	46.70	57.19	41.90	43.87	36.81
	0.00	0.00	0.00	0.00	0.00	0.00	-1.03	0.00	0.00	0.00	0.00	-2.05
	79.42	70.94	64.27	58.22	57.98	52.21	47.37	46.70	57.19	41.90	43.87	34.76
	19.94	17.84	16.34	15.05	14.70	13.62	12.51	11.41	15.06	10.40	10.19	8.76
	59.47	53.10	47.93	43.18	43.28	38.59	34.87	35.30	42.12	31.50	33.68	26.00
	5.78	5.16	4.66	4.20	4.21	3.76	3.38	3.42	4.09	3.06	3.27	2.53
Key metrics
	117.70	107.06	97.92	91.16	88.08	80.59	73.38	71.82	80.50	64.79	66.36	55.36
	46.10%	46.40%	44.60%	44.40%	43.70%	42.90%	42.40%	42.50%	44.00%	41.50%	42.80%	41.70%
	23.30%	23.00%	21.80%	21.00%	21.50%	20.50%	20.10%	20.90%	23.00%	20.20%	21.70%	19.60%
	5.80%	—	5.30%	—	5.30%	—	4.90%	—	—	—	—	—
	26.70%	22.80%	26.60%	21.40%	10.20%	20.40%	11.60%	27.30%	—	—	—	—
	37.40%	37.60%	37.50%	22.30%	2.80%	22.50%	3.50%	35.80%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22
Income statement
	910.96	814.20	681.39	547.80	459.22	462.37
	20.98	20.80	18.32	20.82	14.15	12.83
	931.94	835.00	699.71	568.62	473.37	475.20
	659.09	602.32	505.52	407.89	359.86	327.82
	102.82	94.68	84.76	65.44	58.88	71.50
	0.00	0.00	0.00	—	—	—
	142.71	130.74	112.15	90.22	78.48	70.66
	40.30	33.23	26.74	23.99	20.95	16.45
	100.69	91.82	70.60	57.00	61.72	52.69
	272.58	251.84	211.26	171.25	139.84	116.52
	272.85	232.68	194.19	160.73	113.51	147.38
	0.00	0.00	-1.03	-2.05	0.00	0.00
	272.85	232.68	193.16	158.68	113.51	147.38
	69.17	59.70	49.37	39.04	28.30	36.72
	203.68	172.98	143.79	119.64	85.21	110.67
	19.80	16.81	13.95	11.62	8.29	10.76
Key metrics
	413.84	357.73	290.50	239.67	196.18	216.52
	45.43%	43.90%	42.60%	43.80%	42.70%	46.80%
	22.36%	21.20%	21.10%	21.80%	18.60%	23.90%
	—	19.20%	19.80%	—	—	—
	24.48%	19.50%	24.40%	19.30%	-0.70%	—
	33.96%	20.30%	20.20%	40.40%	-23.00%	—
	—	87.87	128.92	—	—	—
	—	1.56	1.56	—	—	—
	—	0.00	0.00	—	—	—
	—	-39.68	-12.80	—	—	—
	—	-5.2	-7.2	—	—	—
Balance sheet
	—	1,507	1,274	—	—	—
	—	321.90	307.21	—	—	—
	—	39.68	12.80	—	—	—
	—	20.86	14.76	—	—	—
	—	4.89	4.93	—	—	—
	—	7.02	6.25	—	—	—
	—	929.62	723.71	—	—	—
	—	37.56	33.13	—	—	—
	—	123.86	162.61	—	—	—
	—	0.00	0.00	—	—	—
	—	0.00	0.00	—	—	—
	—	0.00	0.00	—	—	—
	—	957.15	799.14	—	—	—
Cash flow
	—	270.59	224.47	—	—	—
	—	-174.22	-181.87	—	—	—
	—	-69.49	-52.05	—	—	—
	—	182.72	95.55	—	—	—

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24
Income statement
	242.00	218.54	206.27	193.08	189.35	174.84	159.85	156.25	168.61	142.42	141.05	129.12
	5.45	9.02	7.23	5.55	5.15	7.42	5.68	4.99	4.80	3.83	3.41	5.25
	247.45	227.56	213.50	198.63	194.51	182.27	165.53	161.25	173.41	146.25	144.46	134.37
	169.52	156.64	145.24	139.60	137.45	130.70	119.39	116.90	119.88	107.94	104.66	98.48
	27.22	24.32	23.67	22.92	22.64	20.04	20.56	19.69	21.33	17.15	17.14	15.62
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—
	35.98	34.90	31.38	30.65	29.94	29.04	25.87	26.16	25.38	24.79	22.41	22.38
	10.82	10.42	8.74	7.95	7.21	6.90	6.58	6.26	6.07	6.05	5.95	6.05
	23.99	22.33	21.42	21.25	19.40	18.33	17.11	16.86	15.37	15.19	14.91	14.40
	71.51	64.68	60.02	56.83	58.26	56.38	49.27	47.93	51.73	44.76	44.25	40.03
	77.93	70.92	68.26	59.03	57.05	51.57	46.15	44.35	53.53	38.31	39.80	35.89
	0.00	0.00	0.00	0.00	0.00	0.00	-1.03	—	—	—	—	-2.05
	77.93	70.92	68.26	59.03	57.05	51.57	45.12	44.35	53.53	38.31	39.80	33.84
	20.00	17.77	15.61	14.82	14.35	13.18	12.00	10.81	14.03	9.45	9.29	8.59
	57.92	53.15	52.65	44.21	42.70	38.39	33.12	33.53	39.50	28.86	30.51	25.25
	5.63	5.17	5.12	4.30	4.15	3.74	3.23	3.26	3.85	2.82	2.98	2.47
Key metrics
	112.74	103.67	98.42	88.23	83.66	76.80	68.81	67.47	74.97	59.55	60.66	54.29
	46.60%	47.40%	47.70%	45.70%	44.20%	43.90%	43.00%	43.20%	44.50%	41.80%	43.00%	42.00%
	23.90%	24.30%	25.50%	22.90%	22.60%	22.00%	20.70%	21.50%	23.40%	20.30%	21.60%	19.60%
	5.80%	—	5.70%	—	5.40%	—	4.80%	—	—	—	—	—
	27.80%	25.00%	29.00%	23.60%	12.30%	22.80%	13.30%	21.00%	—	—	—	—
	35.60%	38.40%	59.00%	31.90%	8.10%	33.00%	8.60%	32.80%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22
Income statement
	859.89	765.43	627.14	525.02	449.58	450.88
	27.25	25.16	19.30	21.44	14.57	12.92
	887.14	790.59	646.44	546.46	464.15	463.80
	611.00	554.20	464.11	391.94	352.88	319.42
	98.13	89.39	78.73	62.85	57.59	68.95
	0.00	0.00	0.00	—	—	—
	132.91	121.39	102.20	86.46	76.50	68.68
	37.93	30.82	24.96	23.71	20.88	16.26
	88.99	80.42	64.52	55.41	61.39	52.14
	253.04	232.17	193.70	163.51	136.52	113.39
	276.14	236.39	182.33	154.52	111.27	144.38
	0.00	0.00	-1.03	-2.05	—	—
	276.14	236.39	181.30	152.47	111.27	144.38
	68.20	58.08	46.29	37.87	28.04	36.28
	207.93	178.31	135.01	114.60	83.23	108.11
	20.22	17.33	13.16	11.21	8.16	10.60
Key metrics
	403.06	347.63	270.78	231.59	193.54	212.78
	46.87%	45.40%	43.20%	44.10%	43.00%	47.20%
	24.18%	23.30%	21.50%	21.80%	18.50%	24.00%
	—	19.90%	19.30%	—	—	—
	26.40%	22.10%	19.50%	16.80%	-0.30%	—
	40.74%	32.10%	17.80%	37.70%	-23.00%	—
	—	90.14	133.60	—	—	—
	—	1.44	1.53	—	—	—
	—	0.00	0.00	—	—	—
	—	-37.76	-9.97	—	—	—
	—	-4.6	-8.2	—	—	—
Balance sheet
	—	1,460	1,224	—	—	—
	—	316.06	295.36	—	—	—
	—	37.76	9.97	—	—	—
	—	21.03	12.46	—	—	—
	—	4.46	3.75	—	—	—
	—	6.80	5.85	—	—	—
	—	857.77	655.58	—	—	—
	—	34.93	30.38	—	—	—
	—	114.00	152.77	—	—	—
	—	0.00	0.00	—	—	—
	—	0.00	0.00	—	—	—
	—	0.00	0.00	—	—	—
	—	943.45	783.53	—	—	—
Cash flow
	—	255.96	206.61	—	—	—
	—	-165.84	-165.37	—	—	—
	—	-63.20	-46.84	—	—	—
	—	165.82	73.01	—	—	—

Compounded growth

Standalone

Sales CAGR 3Y: +19.41%
Sales CAGR 5Y: —
Profit CAGR 3Y: +28.91%
Profit CAGR 5Y: —
Sales YoY (TTM): +26.40%
Profit YoY (TTM): +40.74%

Consolidated

Sales CAGR 3Y: +21.03%
Sales CAGR 5Y: —
Profit CAGR 3Y: +26.62%
Profit CAGR 5Y: —
Sales YoY (TTM): +24.48%
Profit YoY (TTM): +33.96%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 52.45%

Quarter	September 2026	June 2026
Promoter %	52.45%	52.50%

Holder	Type	Holding	Previous	Change
SURENDRANATH REDDY SURA	Promoter	32.20%	32.23%	-0.03%
SUPRITA SURA REDDY	Promoter Group	8.71%	8.72%	-0.01%
SUNIL CHANDRA KONDAPALLY	Promoter Group	7.55%	7.56%	-0.01%
KOTAK MAHINDRA TRUSTEE CO LTD A/C KOTAK BUSINESS C	Public	6.59%	—	—
HDFC MUTUAL FUND - HDFC CHILDRENS FUND	Public	5.57%	—	—
NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA MUL	Public	4.53%	5.64%	-1.11%
GEETHA REDDY SURA	Promoter Group	3.94%	3.94%	0.00%
HSBC MUTUAL FUND - HSBC AGGRESSIVE HYBRID FUND	Public	3.43%	2.69%	+0.74%
AXIS MUTUAL FUND TRUSTEE LIMITED A/C AXIS MUTUAL F	Public	3.42%	3.51%	-0.09%
ICICI PRUDENTIAL SMALLCAP INDEX FUND	Public	2.56%	—	—
MOTILAL OSWAL NIFTY SMALLCAP 250 INDEX FUND	Public	1.29%	1.61%	-0.32%
VERDIPAPIRFONDET ODIN EMERGING MARKETS	Public	1.02%	1.02%	0.00%
BIRUDAVOLU VISHNU PRIYA	Promoter Group	0.03%	0.03%	0.00%
P MADHULIKA	Promoter Group	0.01%	0.01%	0.00%
VENKATA SANJAY KUMAR PULIGORU	Promoter Group	0.01%	0.01%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Dr. Lal Pathlabs Limited	33,039	2,028.95	57.92	25.70%	+16.71% TTM	+8.93% TTM	+28.73%
Vijaya Diagnostic Centre Limited	14,759	1,424.85	72.05	19.20%	+24.48% TTM	+33.96% TTM	+39.02%
Metropolis Healthcare Limited	11,852	582.05	53.57	15.70%	+19.84% TTM	+41.90% TTM	+14.58%
Thyrocare Technologies Limited	7,802	495.25	55.01	33.60%	+21.99% TTM	+13.16% TTM	+9.41%
Nephrocare Health Services Limited	6,069	620.75	48.72	13.70%	—	—	—
SURAKSHA DIAGNOSTIC LIMITED	1,722	333.10	49.46	14.70%	+23.32% TTM	+7.94% TTM	+2.54%
Krsnaa Diagnostics Limited	1,569	482.90	15.97	10.60%	+15.90% TTM	+16.02% TTM	-37.25%
3B BlackBio Dx Limited	1,125	1,330.25	20.29	22.60%	+54.30% TTM	+14.75% TTM	-1.52%
HEALTH X PLATFORM LIMITED	870	271.20	-33.11	—	+28.85% TTM	+82.45% TTM	-8.73%
ONE GLOBAL SERVICE PROVIDER LIMITED S	775	440.70	11.65	65.70%	+161.55% TTM	+178.28% TTM	+21.17%
Gaudium IVF and Women Health Limited	769	107.05	—	23.10%	—	—	—
Aspira Pathlab & Diagnostics Limited S	143	140.35	-318.98	2.90%	+14.50% TTM	-117.58% TTM	+132.68%
Choksi Laboratories Ltd. S	140	203.90	65.77	12.30%	+10.74% TTM	+44.00% TTM	+38.05%
STAR IMAGING AND PATH LAB LIMITED	129	68.90	—	22.60%	—	—	-51.78%
MODERN DIAGNOSTIC & RESEARCH CENTRE LIMITED S	84	57.00	—	11.20%	—	—	—
N.G.Industries Ltd. S	35	100.00	17.39	6.30%	+2.18% TTM	-74.06% TTM	-23.28%
BANDARAM PHARMA PACKTECH LIMITED	34	19.03	25.81	4.70%	+114.59% TTM	+454.17% TTM	-22.14%
Sharma East India Hospitals And Res S	31	87.05	24.11	14.20%	+14.13% TTM	-9.85% TTM	-38.28%
Deccan Health Care Limited	29	12.00	11.40	3.20%	-0.37% TTM	+145.63% TTM	-29.41%
Chennai Meenakshi Multispeciality Hospital Ltd. S	28	36.78	-32.26	-2.80%	+0.08% TTM	+6.59% TTM	-29.27%
Tejnaksh Healthcare Limited	26	12.83	21.19	5.90%	-12.97% TTM	-33.15% TTM	-27.02%
SAMSRITA LABS LIMITED	25	11.93	-3.33	-73.40%	—	—	-43.35%
Transgene Biotek Ltd.	17	2.57	-12.11	-0.50%	-14.81% TTM	-23.85% TTM	-28.21%
Looks Health Services Limited S	11	10.08	504.00	0.20%	-41.89% TTM	-57.14% TTM	+101.20%
Dolphin Medical Services Ltd. S	11	7.11	59.25	0.60%	-1.25% TTM	+700.00% TTM	+246.83%

Filings & corporate actions

Recent announcements

Audio recording of the Earning Conference Call for Q2 - FY 20274 Nov 2026 · Company Update / Analyst / Investor Meet
Investor Presentation on unaudited Financial Results for Quarter and Half Year Ended September 30, 20263 Nov 2026 · Company Update / Investor Presentation
Press-release on unaudited Financial Results for the Quarter and half year ended September 30, 20263 Nov 2026 · Company Update / Press Release / Media Release
Appointment of Mr. Rahul Jain (ICSI M. No. A62949), as Company Secretary and Compliance Officer of the Company3 Nov 2026 · Company Update / Appointment of Company Secretary / Compliance Officer
Submission of the Unaudited Financial Results for the Quarter and Half year ended September 30, 20263 Nov 2026 · Result / Financial Results
The Board of Directors in their meeting held on November 03, 2026 have approved the financial results for the quarter and Half year ended September 30, 20263 Nov 2026 · Board Meeting / Outcome of Board Meeting
Initmation of Earning Conference Call28 Oct 2026 · Company Update / Analyst / Investor Meet
Vijaya Diagnostic Centre Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve the unaudited Financial ....28 Oct 2026 · Board Meeting / Board Meeting
Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the Quarter ending September 30, 2026.6 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
The Trading Window for dealing in securities of the company for all the Designated Persons (DP) and their immediate relatives shall remain closed w.e.f. Thursday, October 1, 2026 till the ....28 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Voting Results along with the Scrutiniser Report of the 24th AGM Held on 24th September 2026.26 Sep 2026 · AGM/EGM / AGM
Summary of the proceedings of the 24th AGM of the Company held on Thursday, 24th September 2026 at 11:00 am through VC/OAVM.24 Sep 2026 · AGM/EGM / AGM
100% acquisition of integrated diagnostic business undertaking of Arya Wellness Centre, Guwahati, Assam.11 Sep 2026 · Company Update / Investor Presentation
Execution of Business Transfer Agreement ("BTA") for 100% acquisition of integrated diagnostic business undertaking of Arya Wellness Centre, Guwahati, Assam on slump sale.11 Sep 2026 · Company Update / Press Release / Media Release
Outcome of Board Meeting under Regulation 30 of SEBI (LODR) Regulations, 2015 - Approval for Execution of Business Transfer Agreement (BTA) for 100% acquisition of the integrated diagnostic ....11 Sep 2026 · Others / Outcome without intimation
Institutional Investor Meeting hosted by Emkay Global.2 Sep 2026 · Company Update / Analyst / Investor Meet
Appointment of Chief Information Officer (CIO)2 Sep 2026 · Company Update / Change in Management
Intimation of 24th AGM - Post Dispatch Newspaper Advertisement27 Aug 2026 · Company Update / Newspaper Publication
Resignation of Company secretary26 Aug 2026 · Company Update / Change in Management
Weblink to Shareholders26 Aug 2026 · Company Update / General
Record date for final dividend and e-voting for AGM26 Aug 2026 · Corp. Action / Record Date
BRSR for FY 2025-2626 Aug 2026 · Others / Business Responsibility and Sustainability Reporting (BRSR)
Annual Report for FY 2025-2626 Aug 2026 · Others / Reg. 34 (1) Annual Report
Notice of 24th Annual General Meeting of the Company26 Aug 2026 · AGM/EGM / AGM
Cessation of Dr. Manjula Anagani as Independent Director due to completion of tenure w.e.f closing of business hours on 21.08.202621 Aug 2026 · Company Update / Cessation
Cessation of Dr. Manjula Anagani as Independent Director on completion of tenure w.e.f 21.08.202621 Aug 2026 · Company Update / Change in Management
Scrutinizer report for Postal Ballot21 Aug 2026 · AGM/EGM / Postal Ballot
Outcome of Postal Ballot21 Aug 2026 · AGM/EGM / Postal Ballot
Paper adv for pre-dispatch of AGM notice19 Aug 2026 · Company Update / Newspaper Publication
Information relating to 24th Annual general meeting, cut-off date for remote e-voting and e-voting at AGM19 Aug 2026 · AGM/EGM / AGM
Earnings call Transcript for Q1 Fy 27 held on August 07, 202610 Aug 2026 · Company Update / Earnings Call Transcript
Copy of News paper publication for Q1 results8 Aug 2026 · Company Update / Newspaper Publication
earnings call for Q1 FY 2026-277 Aug 2026 · Company Update / Analyst / Investor Meet
Audit Committee and Independent Director report certifying the distribution of proceeds to shareholders of Medinova Diagnostic services Limited pursuant to scheme of Amalgamation7 Aug 2026 · Company Update / General
Press Release on Q1 Un-audited financial results for FY 276 Aug 2026 · Company Update / Press Release / Media Release
Investor Presentation on Un-audited results for the Quarter ended June 30, 20266 Aug 2026 · Company Update / Investor Presentation
Press Release on Un-audited financial results for the quarter ended June 30, 20266 Aug 2026 · Company Update / Press Release / Media Release
Un-audited financial results for the quarter ended June 30, 2026 on consolidated & Standalone basis6 Aug 2026 · Result / Financial Results
The Board of Directors in their meeting held on August 6, 2026 have approved the financial results for the quarter ended June 30, 20266 Aug 2026 · Board Meeting / Outcome of Board Meeting
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for HDFC Mutual Fund29 Jul 2026 · Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

Corporate actions

Purpose	Ex date	Record date	Payment date
Final Dividend - Rs. - 2.0000	16 Sep 2026	16 Sep 2026	—
Final Dividend - Rs. - 2.0000	29 Aug 2025	29 Aug 2025	—
Final Dividend - Rs. - 1.0000	30 Aug 2024	30 Aug 2024	—

Board meetings

3 Nov 2026 Board Meeting - Financial Results
6 Aug 2026 Board Meeting - Financial Results